Cape Town Clinical Research Centre

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression3 trials
• Insomnia1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Completed3 trials

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Janssen-Cilag Ltd.1 trial

Closed trials

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

  NCT04829318· Phase 4· Janssen-Cilag Ltd.· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Janssen Research & Development, LLC· Source